Tafamidis dramatically improved severe proteinuria in a patient with TTR V30M hereditary ATTR amyloidosis

Shu-Ichi IkedaIntractable Disease Care Centre, Shinshu University Hospital, Matsumoto, Japan; Correspondence[email protected]

Akiyo HinenoIntractable Disease Care Centre, Shinshu University Hospital, Matsumoto, Japan; ;Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Matsumoto, Japan;

Tohru IchikawaDepartment of Nephrology, Nagano Red Cross Hospital, Nagano, Japan;

Mutsuki MakinoDepartment of Pathology, Shinonoi Genral Hospital, Nagano, Japan

References

Hofer P-Å, Andersson R. Postmortem findings in primary familial amyloidosis with polyneuropathy. A study based on six cases from Northern Sweden. Acta Pathol Microbiol Scand Sect A. 1975;83:309–322.
PubMedGoogle Scholar
Ikeda S, Hanyu N, Hongo M, et al. Hereditary generalized amyloidosis with polyneuropathy. Clinicopathological study of 65 Japanese patients. Brain. 1987;110:315–337.
PubMed Web of Science ®Google Scholar
Coelho T, Maia LF, da Silva AM, et al. Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy. J Neurol. 2013;260:2802–2814.
PubMed Web of Science ®Google Scholar
Oguchi K, Takei Y, Ikeda S. Value of renal biopsy in the prognosis of liver transplantation in familial amyloid polyneuropathy ATTR Val30Met patients. Amyloid. 2006;13:99–107.
PubMed Web of Science ®Google Scholar
Tsuchiya-Suzuki A, Yazaki M, Sekijima Y, et al. Steady turnover of amyloid fibril proteins in gastric mucosa after liver transplantation in familial amyloid polyneuropathy. Amyloid. 2013;20:156–163.
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Tafamidis dramatically improved severe proteinuria in a patient with TTR V30M hereditary ATTR amyloidosis

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Tafamidis dramatically improved severe proteinuria in a patient with TTR V30M hereditary ATTR amyloidosis

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date